Assignee
VIRXSYS CORP
US·9 granted patents·11 pending applications·145 citations·filing 2000–2014
Top patents by PatentIndex Score
20 records- 0193US6627442B1Methods for stable transduction of cells with hiv-derived viral vectorsVIRXSYS CORP·Filed 2000·Granted Sep 30, 2003·114 cites·30 claims
- 0285US7399753B2Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2003·Granted Jul 15, 2008·13 cites·15 claims
- 0381US7968334B2Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicingVIRXSYS CORP·Filed 2005·Granted Jun 28, 2011·4 cites·25 claims
- 0477US8053232B2Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicingVIRXSYS CORP·Filed 2005·Granted Nov 8, 2011·4 cites·24 claims
- 0577US6835568B2Regulated nucleic acid expression systemVIRXSYS CORP·Filed 2001·Granted Dec 28, 2004·6 cites·19 claims
- 0676US7871795B2Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteinsVIRXSYS CORP·Filed 2005·Granted Jan 18, 2011·2 cites·10 claims
- 0774US7879321B2Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide productionVIRXSYS CORP·Filed 2005·Granted Feb 1, 2011·2 cites·16 claims
- 0864US2015030627A1Trans-complementing, replication deficient lentiviral vectors and methods for making and using themVIRXSYS CORP·Filed 2014·Application pending·0 cites
- 0960US2009081682A1High-throughput methods for identifying gene function using lentiviral vectorsVIRXSYS CORP·Filed 2008·Application pending·0 cites
- 1059US8043611B2Regulated nucleic acid expression systemVIRXSYS CORP·Filed 2004·Granted Oct 25, 2011·0 cites·31 claims
- 1158US7427474B2High-throughput methods for identifying gene function using lentiviral vectorsVIRXSYS CORP·Filed 2003·Granted Sep 23, 2008·0 cites·35 claims
- 1258US2009203143A1Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2008·Application pending·0 cites
- 1356US2006281128A1Compositions and methods using lentivirus-based vectors for generating immune responsesVIRXSYS CORP·Filed 2006·Application pending·0 cites
- 1448US2011263015A1Compositions and methods for generation of pluripotent stem cellsVIRXSYS CORP·Filed 2009·Application pending·0 cites
- 1548US2011207226A1Non-integrating lenti/adeno-associated virus hybrid vector systemVIRXSYS CORP·Filed 2009·Application pending·0 cites
- 1642US2015025127A1Compositions and methods for inducing apoptosisVIRXSYS CORP·Filed 2012·Application pending·0 cites
- 1742US2011244519A1Use of rna trans-splicing for antibody gene transfer and antibody polypeptide productionVIRXSYS CORP·Filed 2011·Application pending·0 cites
- 1840US2008274091A1Autologous T Cell Manufacturing ProcessesVIRXSYS CORP·Filed 2006·Application pending·0 cites
- 1938US2006003452A1Vector packaging cell lineVIRXSYS CORP·Filed 2005·Application pending·0 cites
- 2035US2007036783A1Antibody complexesVIRXSYS CORP·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →